BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26002138)

  • 21. Clinical and molecular characteristics of Klebsiella pneumoniae ventilator-associated pneumonia in mainland China.
    Guo S; Xu J; Wei Y; Xu J; Li Y; Xue R
    BMC Infect Dis; 2016 Oct; 16(1):608. PubMed ID: 27782809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae.
    Wu H; Li D; Zhou H; Sun Y; Guo L; Shen D
    Microb Pathog; 2017 Mar; 104():254-262. PubMed ID: 28132768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of ompK36 allele groups on clinical characteristics and virulence features of Klebsiella pneumoniae from bacteremia.
    Du F; Wei DD; Wan LG; Cao XW; Zhang W; Liu Y
    J Microbiol Immunol Infect; 2019 Oct; 52(5):779-787. PubMed ID: 30348614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):311-7. PubMed ID: 18787738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
    Harada S; Aoki K; Yamamoto S; Ishii Y; Sekiya N; Kurai H; Furukawa K; Doi A; Tochitani K; Kubo K; Yamaguchi Y; Narita M; Kamiyama S; Suzuki J; Fukuchi T; Gu Y; Okinaka K; Shiiki S; Hayakawa K; Tachikawa N; Kasahara K; Nakamura T; Yokota K; Komatsu M; Takamiya M; Tateda K; Doi Y
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
    Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
    Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare-associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: the time has come.
    Corcione S; Cardellino CS; Calcagno A; Fossati L; Costa C; Cavallo R; Di Perri G; De Rosa FG
    Clin Infect Dis; 2014 Jul; 59(2):321-2. PubMed ID: 24771335
    [No Abstract]   [Full Text] [Related]  

  • 30. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.
    Yu VL; Hansen DS; Ko WC; Sagnimeni A; Klugman KP; von Gottberg A; Goossens H; Wagener MM; Benedi VJ;
    Emerg Infect Dis; 2007 Jul; 13(7):986-93. PubMed ID: 18214169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.
    Namikawa H; Niki M; Niki M; Yamada K; Nakaie K; Sakiyama A; Oinuma KI; Tsubouchi T; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2291-2297. PubMed ID: 31605255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan.
    Lin WH; Tseng CC; Wu AB; Yang DC; Cheng SW; Wang MC; Wu JJ
    J Microbiol Immunol Infect; 2015 Jun; 48(3):276-83. PubMed ID: 24291619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial Resistance of Hypervirulent
    Lee CR; Lee JH; Park KS; Jeon JH; Kim YB; Cha CJ; Jeong BC; Lee SH
    Front Cell Infect Microbiol; 2017; 7():483. PubMed ID: 29209595
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
    Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
    Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
    Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital.
    Namikawa H; Yamada K; Sakiyama A; Imoto W; Yamairi K; Shibata W; Yoshii N; Niki M; Nakaie K; Oinuma KI; Tsubouchi T; Niki M; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):84-88. PubMed ID: 31256940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A; Kiratisin P; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):671-4. PubMed ID: 18624669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.